---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-112912"
form_type: "8-K"
ticker: "FENC"
cik: "0001211583"
company_name: "FENNEC PHARMACEUTICALS INC."
filed_at: "2025-11-17T23:59:59+00:00"
generated_at: "2026-05-16T19:07:47.222765+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Fennec prices $35M public offering of 4.7M shares at $7.50/share to repay debt

## Summary
- Offering of 4,666,667 common shares at $7.50 per share; gross proceeds ~$35M.
- Underwriters granted 30-day option to purchase up to 700,000 additional shares.
- Net proceeds to repurchase and redeem certain indebtedness and for working capital.
- Closing expected November 17, 2025, subject to customary conditions.
- Joint book-running managers: Piper Sandler & Co. and Craig-Hallum Capital Group.

## SEC filing metadata
- accession: 0001104659-25-112912
- form_type: 8-K
- ticker: FENC
- cik: 0001211583
- company_name: FENNEC PHARMACEUTICALS INC.
- filed_at: 2025-11-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1211583/000110465925112912/0001104659-25-112912-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1211583/000110465925112912/tm2531308d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-112912
- JSON: https://secwatch.observer/filing/0001104659-25-112912.json
- Plain text: https://secwatch.observer/filing/0001104659-25-112912.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.